ABCG2 and renal cell carcinoma: Moreover, the higher expression of ABCG2 in spheres and sunitinib-resistant cell lines of RCC-53 compared to the adherent cell line, showed that further in-depth research, such as analyzing tumorigenicity of different ABCG2 expressing sub-phenotypes in RCC-53 cell lines, can be organized in the future.